Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
AbstractIn this perspective, we present our assessment of all of the known accumulated evidence on the role of neoadjuvant therapy in the management of borderline resectable pancreatic cancer highlighting the gaps in the data, the current regimens used and providing a brief insight into the way forward.
Source: Indian Journal of Surgical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | India Health | Neoadjuvant Therapy | Pancreas | Pancreatic Cancer